Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
McKinsey
AstraZeneca
Baxter
Express Scripts

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Tesevatinib


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Tesevatinib?

Tesevatinib is an investigational drug.

There have been 7 clinical trials for Tesevatinib. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.

The most common disease conditions in clinical trials are Polycystic Kidney Diseases, Kidney Diseases, and Polycystic Kidney, Autosomal Dominant. The leading clinical trial sponsors are Kadmon Corporation, LLC and [disabled in preview].

There are one hundred and six US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Tesevatinib
TitleSponsorPhase
Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKDKadmon Corporation, LLCPhase 2
A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)Kadmon Corporation, LLCPhase 1
Study of Tesevatinib Monotherapy in Patients With Recurrent GlioblastomaKadmon Corporation, LLCPhase 2

See all Tesevatinib clinical trials

Clinical Trial Summary for Tesevatinib

Top disease conditions for Tesevatinib
Top clinical trial sponsors for Tesevatinib

See all Tesevatinib clinical trials

US Patents for Tesevatinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tesevatinib ⤷  Try it Free Antibody drug conjugates Novartis AG (Basel, CH) ⤷  Try it Free
Tesevatinib ⤷  Try it Free Human anti-VEGFR-2/KDR antibodies KADMON CORPORATION, LLC (New York, NY) ⤷  Try it Free
Tesevatinib ⤷  Try it Free Heterocyclic estrogen receptor modulators and uses thereof Genentech, Inc. (South San Francisco, CA) ⤷  Try it Free
Tesevatinib ⤷  Try it Free Gene fusions and gene variants associated with cancer LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA) ⤷  Try it Free
Tesevatinib ⤷  Try it Free Azabicyclo derivatives, process for preparation thereof and medical use thereof Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (Shanghai, CN) Yangtze River Pharmaceutical Group Co., Ltd. (Jiangsu, CN) ⤷  Try it Free
Tesevatinib ⤷  Try it Free Antibody drug conjugates Novartis AG (Basel, CH) ⤷  Try it Free
Tesevatinib ⤷  Try it Free Rho kinase inhibitors KADMON CORPORATION, LLC (New York, NY) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tesevatinib

Drugname Country Document Number Estimated Expiration Related US Patent
Tesevatinib Argentina AR102649 2034-11-14 ⤷  Try it Free
Tesevatinib Australia AU2015347015 2034-11-14 ⤷  Try it Free
Tesevatinib Brazil BR112017009813 2034-11-14 ⤷  Try it Free
Tesevatinib Canada CA2967188 2034-11-14 ⤷  Try it Free
Tesevatinib Chile CL2017001217 2034-11-14 ⤷  Try it Free
Tesevatinib China CN108064244 2034-11-14 ⤷  Try it Free
Tesevatinib Colombia CO2017004782 2034-11-14 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
McKinsey
AstraZeneca
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.